Bank of Montreal’s Niagen Bioscience NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,168
Closed -$11K 5030
2021
Q1
$11K Sell
1,168
-5,220
-82% -$41.4K ﹤0.01% 4346
2020
Q4
$30K Buy
6,388
+4,497
+238% +$21.9K ﹤0.01% 4231
2020
Q3
$10K Sell
1,891
-1,377
-42% -$6.64K ﹤0.01% 4144
2020
Q2
$16K Buy
+3,268
New +$14.6K ﹤0.01% 3961
2020
Q1
Sell
-5,153
Closed -$22K 4813
2019
Q4
$22K Buy
5,153
+1,694
+49% +$6.02K ﹤0.01% 4279
2019
Q3
$14K Buy
3,459
+222
+7% +$947 ﹤0.01% 4283
2019
Q2
$15K Buy
+3,237
New +$13.8K ﹤0.01% 4348
2019
Q1
Sell
-544
Closed -$2K 4817
2018
Q4
$2K Buy
544
+278
+105% +$966 ﹤0.01% 4431
2018
Q3
$1K Sell
266
-7
-3% -$30 ﹤0.01% 4616
2018
Q2
$1K Buy
+273
New +$1.04K ﹤0.01% 4603
2017
Q4
Sell
-36,422
Closed -$156K 4357
2017
Q3
$156K Sell
36,422
-7,546
-17% -$27.6K ﹤0.01% 2768
2017
Q2
$168K Buy
+43,968
New +$139K ﹤0.01% 2742

Other funds holding NAGE

Bank of Montreal's NAGE Position: Q2 2021 in Review

Bank of Montreal sold out of Niagen Bioscience (NAGE) in Q2 2021, closing a stake of 1,168 shares — an estimated $11K sold.

Bank of Montreal first reported a position in NAGE in Q2 2017 and held it in 12 quarters. The position peaked at $168K in Q2 2017. 101 funds tracked by Wall St. Rank hold NAGE as of Q2 2021.

  • Bank of Montreal reported no remaining Niagen Bioscience position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 1,168 Niagen Bioscience shares in Q2 2021, an estimated $11K.
  • Bank of Montreal first reported a position in Niagen Bioscience in Q2 2017 and held it in 12 quarters.
  • Bank of Montreal's Niagen Bioscience position peaked at $168K in Q2 2017.
  • 101 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.